Research ArticleClinical Studies

First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer – Evaluation of Feasibility and Review of Current Recommendations

WOLFRAM MALTER, CHRISTIAN EICHLER, BETTINA HANSTEIN, PETER MALLMANN and JOHANNES HOLTSCHMIDT
In Vivo May 2020, 34 (3) 1207-1213; DOI: https://doi.org/10.21873/invivo.11894

Article Information

vol. 34 no. 3 1207-1213
DOI 
https://doi.org/10.21873/invivo.11894
PubMed 
32354911
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received February 27, 2020
  • Revision received March 15, 2020
  • Accepted March 16, 2020
  • Published online April 29, 2020.
Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. WOLFRAM MALTER*,
  2. CHRISTIAN EICHLER*,
  3. BETTINA HANSTEIN,
  4. PETER MALLMANN and
  5. JOHANNES HOLTSCHMIDT⇑
  1. Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
  1. Correspondence to: Johannes Holtschmidt, MD, Kerpener Strasse 34, 50931 Cologne, Germany. Tel: +49 2214784945, Fax: +49 2214783411, e-mail: johannes.holtschmidt{at}gmail.com

  1. ↵* These Authors contributed equally to this study.

View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer – Evaluation of Feasibility and Review of Current Recommendations
WOLFRAM MALTER, CHRISTIAN EICHLER, BETTINA HANSTEIN, PETER MALLMANN, JOHANNES HOLTSCHMIDT
In Vivo May 2020, 34 (3) 1207-1213; DOI: 10.21873/invivo.11894
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords